{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0001525",
      "entity_text" : "neovascularization",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06449",
      "entity_text" : "integrin alpha5beta1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "A small peptide antagonist (amino-acid sequence PHSCN) to integrin alpha5beta1 significantly reduced neovascularization and formation of metastases in an animal model of prostate carcinoma that expresses integrin alpha5beta1 XREF_BIBR, XREF_BIBR - XREF_BIBR.",
  "reading_complete" : "2020-08-03T17:48:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:45:05Z",
  "trigger" : "reduced",
  "evidence" : [ "integrin alpha5beta1 significantly reduced neovascularization" ],
  "pmc_id" : "3086610",
  "score" : 0
}